Business Wire

ExaGrid Launches Version 6.2 with 5 Key Performance, Integration, and Security Features

15.11.2022 16:00:00 EET | Business Wire | Press release

Share

ExaGrid ®, the industry's only Tiered Backup Storage solution, today announced the release of software Version 6.2, which begins shipping in early December 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221115005053/en/

ExaGrid is constantly driving improvements in five key areas: ingest performance for the fastest backups and shortest backup window, fastest restores to keep user productive, scalability to ensure a fixed-length backup window as data grows as well as no forklift upgrades and no planned product obsolescence, lowest cost up front and over time, and a strong security story including the ability to recover after a security attack such as ransomware.

ExaGrid's Unique Architecture employs:

  • Front-end disk-cache Landing Zone for fast backups
    • Optimized for large backup jobs, parallel backup support (job concurrency), no inline deduplication to slow backups down, encryption at the drive level to increase performance, and integrations with key backup applications for front-end load balancing.
    • Fast restores as the data is in the native backup application format and is non-deduplicated to avoid compute-intensive data rehydration
  • Scale-out architecture
    • Keeps a fixed-length backup window as data grows
    • Eliminates disruptive and costly forklift upgrades
    • Can mix and match any age and any size appliance eliminating planned product obsolescence to reduce costs over time
  • Non-network-facing Repository Tier
    • Deduplicated data to efficiently store all current and long-term retention data for cost savings
    • Not visible or accessible from the network
    • Delayed deletes to ensure data deleted on the front-end Landing Zone is not immediately deleted in the repository ensuring data is ready for recovery after an attack
    • Immutable data objects that are not deleted, changed, or modified to ensure recovery from encryption events

5 Key Updates in Version 6.2

Veritas NetBackup Single Target Storage Pool
ExaGrid has integrated with NetBackup and presents a single virtualized target pool of storage at each site. This approach automates job management between Veritas NetBackup and ExaGrid, where backup data is automatically sent to available ExaGrid appliances for front-end performance. Backup data is directed into any ExaGrid appliance as all ExaGrid appliances are in a single integrated scale-out system. ExaGrid automatically load balances all data across all non-network facing repositories for full storage utilization and globally deduplicates data across all repositories for maximum storage savings.

Veritas IT Analytics
ExaGrid has integrated with Veritas IT analytics, allowing reporting on key data statistics from the ExaGrid storage. This allows enterprises to include ExaGrid Tiered Backup storage along with unified insights for backup, storage, and virtual infrastructure.

ExaGrid, including Single Target Storage Pool and support of NetBackup Analytics, now has a total of 9 Veritas NetBackup integrations, including support of NetBackup Accelerator, OST Integration, integration with NetBackup media server hardware, AIR (Auto Image Replication), and GRT (granular level restore), optimized deduplication, and instant recovery.

New ExaGrid Cloud Tier Features and Integrations
ExaGrid physical appliances on premise in the data center can replicate data to the public clouds for disaster recovery (DR). ExaGrid has improved the performance and scalability of its ExaGrid Cloud Tier for Amazon AWS and has added ExaGrid Cloud Tier support for Microsoft Azure. ExaGrid physical on-site appliances replicate the deduplicated data in the repository to AWS or Azure, which is then written to AWS or Azure storage for long-term retention. The deduplicated data uses about 1/50th of the bandwidth versus undeduplicated data. ExaGrid encrypts the data in transit, and the cloud providers encrypt the data at rest.

Improved Performance
ExaGrid has improved its Adaptive Deduplication performance, increasing the Repository Tier's overall performance and further increasing the scalability and recovery points of data in the non-network-facing Repository Tier and offsite disaster recovery copy.

ExaGrid has greatly improved the performance of Veeam synthetic fulls (Veeam V12) by adding support for Veeam's Fast Clone technology in ExaGrid repositories. The synthetics fulls are at least 30X faster than previous versions.

Improved Security
ExaGrid has a strong ransomware recovery solution with a non-network-facing Repository Tier (tiered air gap), delayed delete policy, immutable data objects, and 2FA support. ExaGrid has added two new features:

  • An alert on large delete is generated as an early detection warning if a threat actor/hacker is trying to delete a large amount of recently ingested data (above a set operational threshold) on the ExaGrid front-end Landing Zone.
  • An alert on data deduplication change is generated when the deduplication ratio changes below a set threshold signaling that a large amount of encrypted data is being sent to the ExaGrid front-end Landing Zone or that the data on the Landing Zone is being encrypted.

These features add an early alert warning in addition to the current ExaGrid Retention Time-Lock (RTL) functionality, ensuring that the data in the non-network-facing tier is available for recovery.

"ExaGrid continues to focus on improving backup and restore performance, scalability, cost savings, and security," said Bill Andrews, CEO of ExaGrid. "Since ExaGrid is 100% focused on backup storage, all we do is obsess about making backup storage better. We are the only company worldwide focusing solely on backup storage. It is a testament to the product that we are installed in over 80 countries worldwide, have 99% of our customers on yearly maintenance and support contracts, have a NPS of +81, and a customer retention rate of 95%. All of these numbers are market-leading in storage. ExaGrid is a financially healthy and growing company that is cash positive, P&L positive, and EBITDA positive. The combination of our product, customer support, and financial strength is why customers trust ExaGrid Tiered Backup Storage."

About ExaGrid
ExaGrid provides Tiered Backup Storage with a unique disk-cache Landing Zone, long-term retention repository, and scale-out architecture. ExaGrid's Landing Zone provides for the fastest backups, restores, and instant VM recoveries. The retention repository offers the lowest cost for long-term retention. ExaGrid's scale-out architecture includes full appliances and ensures a fixed-length backup window as data grows, eliminating expensive forklift upgrades and product obsolescence. ExaGrid offers the only two-tiered backup storage approach with a non-network-facing tier, delayed deletes, and immutable objects to recover from ransomware attacks.

ExaGrid has physical sales and pre-sales systems engineers in the following countries: Argentina, Australia, Benelux, Brazil, Canada, Chile, CIS, Colombia, Czech Republic, France, Germany, Hong Kong, Iberia, India, Israel, Japan, Mexico, Nordics, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Turkey, United Arab Emirates, United Kingdom, United States, and other regions.

Visit us at exagrid.com or connect with us on LinkedIn . See what our customers have to say about their own ExaGrid experiences and learn why they now spend significantly less time on backup in our customer success stories . Check out our 100+ Gartner Peer Insight Reviews . ExaGrid is proud of our +81 NPS score.

ExaGrid is a registered trademark of ExaGrid Systems, Inc. All other trademarks are the property of their respective holders.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Mary Domenichelli
ExaGrid
mdomenichelli@exagrid.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye